Key Market Indicators
Sales of digestive system disorder medicines in Australia are set to reach over $1 billion by 2026. In 2021, they were worth $1,020 million, a 0.2% year-on-year increase. Since 1995, the market has decreased by 0.3% year-on-year. Australia was the ninth biggest market in 2021, behind Switzerland with $1,020 million. Japan, South Korea and Canada occupied positions two, three and four respectively.